ArticleJACC. Basic to translational science2019

SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart.

Ven G Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.